Viemed Healthcare, Inc. (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.
Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States. The company partners with hospitals, skilled nursing facilities, and physician practices to facilitate smooth transitions from acute care to the home setting. Viemed’s model emphasizes early intervention, patient education, and close monitoring to reduce hospital readmissions and improve quality of life for individuals with chronic respiratory conditions such as COPD, neuromuscular diseases, and spinal cord injuries.
In addition to equipment delivery, Viemed provides telemonitoring and home health services, enabling continuous remote oversight of patient ventilation parameters and clinical status. Its clinical team works collaboratively with referring physicians to adjust care plans in real time and to address emerging respiratory needs. Through these integrated services, Viemed aims to enhance patient outcomes, lower overall healthcare costs, and set a standard for home respiratory care across its service regions.
AI Generated. May Contain Errors.
Free VMD Stock Alerts